FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2955950503> ?p ?o ?g. }

• W2955950503 endingPage "12230" @default.
• W2955950503 startingPage "12220" @default.
• W2955950503 abstract "Neuroactive steroids (NASs) are synthesized within the brain and exert profound effects on behavior. These effects are primarily believed to arise from the activities of NASs as positive allosteric modulators (PAMs) of the GABA-type A receptor (GABAAR). NASs also activate a family of G protein–coupled receptors known as membrane progesterone receptors (mPRs). Here, using surface-biotinylation assays and electrophysiology techniques, we examined mPRs’ role in mediating the effects of NAS on the efficacy of GABAergic inhibition. Selective mPR activation enhanced phosphorylation of Ser-408 and Ser-409 (Ser-408/9) within the GABAAR β3 subunit, which depended on the activity of cAMP-dependent protein kinase A (PKA) and protein kinase C (PKC). mPR activation did not directly modify GABAAR activity and had no acute effects on phasic or tonic inhibition. Instead, mPR activation induced a sustained elevation in tonic current, which was blocked by PKA and PKC inhibition. Substitution of Ser-408/9 to alanine residues also prevented the effects of mPR activation on tonic current. Furthermore, this substitution abolished the effects of sustained NAS exposure on tonic inhibition. Interestingly, the allosteric effects of NAS on GABAergic inhibition were independent of Ser-408/9 in the β3 subunit. Additionally, although allosteric effects of NAS on GABAergic inhibition were sensitive to a recently developed “NAS antagonist,” the sustained effects of NAS on tonic inhibition were not. We conclude that metabotropic effects of NAS on GABAergic inhibition are mediated by mPR-dependent modulation of GABAAR phosphorylation. We propose that this mechanism may contribute to the varying behavioral effects of NAS. Neuroactive steroids (NASs) are synthesized within the brain and exert profound effects on behavior. These effects are primarily believed to arise from the activities of NASs as positive allosteric modulators (PAMs) of the GABA-type A receptor (GABAAR). NASs also activate a family of G protein–coupled receptors known as membrane progesterone receptors (mPRs). Here, using surface-biotinylation assays and electrophysiology techniques, we examined mPRs’ role in mediating the effects of NAS on the efficacy of GABAergic inhibition. Selective mPR activation enhanced phosphorylation of Ser-408 and Ser-409 (Ser-408/9) within the GABAAR β3 subunit, which depended on the activity of cAMP-dependent protein kinase A (PKA) and protein kinase C (PKC). mPR activation did not directly modify GABAAR activity and had no acute effects on phasic or tonic inhibition. Instead, mPR activation induced a sustained elevation in tonic current, which was blocked by PKA and PKC inhibition. Substitution of Ser-408/9 to alanine residues also prevented the effects of mPR activation on tonic current. Furthermore, this substitution abolished the effects of sustained NAS exposure on tonic inhibition. Interestingly, the allosteric effects of NAS on GABAergic inhibition were independent of Ser-408/9 in the β3 subunit. Additionally, although allosteric effects of NAS on GABAergic inhibition were sensitive to a recently developed “NAS antagonist,” the sustained effects of NAS on tonic inhibition were not. We conclude that metabotropic effects of NAS on GABAergic inhibition are mediated by mPR-dependent modulation of GABAAR phosphorylation. We propose that this mechanism may contribute to the varying behavioral effects of NAS." @default.
• W2955950503 created "2019-07-12" @default.
• W2955950503 creator A5002857264 @default.
• W2955950503 creator A5011923747 @default.
• W2955950503 creator A5020338130 @default.
• W2955950503 creator A5034817273 @default.
• W2955950503 creator A5036745515 @default.
• W2955950503 creator A5040906898 @default.
• W2955950503 creator A5050110044 @default.
• W2955950503 creator A5054490724 @default.
• W2955950503 creator A5084231456 @default.
• W2955950503 date "2019-08-01" @default.
• W2955950503 modified "2023-10-17" @default.
• W2955950503 title "Metabotropic, but not allosteric, effects of neurosteroids on GABAergic inhibition depend on the phosphorylation of GABAA receptors" @default.
• W2955950503 cites W1590163747 @default.
• W2955950503 cites W1892249233 @default.
• W2955950503 cites W1967516237 @default.
• W2955950503 cites W1973557149 @default.
• W2955950503 cites W1976278777 @default.
• W2955950503 cites W1983157748 @default.
• W2955950503 cites W1985851148 @default.
• W2955950503 cites W1994532676 @default.
• W2955950503 cites W2012255717 @default.
• W2955950503 cites W2015279480 @default.
• W2955950503 cites W2018373327 @default.
• W2955950503 cites W2020053580 @default.
• W2955950503 cites W2027642061 @default.
• W2955950503 cites W2033129564 @default.
• W2955950503 cites W2053500820 @default.
• W2955950503 cites W2083308326 @default.
• W2955950503 cites W2083418663 @default.
• W2955950503 cites W2090820401 @default.
• W2955950503 cites W2113971423 @default.
• W2955950503 cites W2115763498 @default.
• W2955950503 cites W2125367143 @default.
• W2955950503 cites W2142269145 @default.
• W2955950503 cites W2154223842 @default.
• W2955950503 cites W2179748092 @default.
• W2955950503 cites W22744554 @default.
• W2955950503 cites W2316059958 @default.
• W2955950503 cites W2412393511 @default.
• W2955950503 cites W2531903693 @default.
• W2955950503 cites W2590645778 @default.
• W2955950503 cites W2626607634 @default.
• W2955950503 cites W2725233258 @default.
• W2955950503 cites W2756488677 @default.
• W2955950503 cites W2762954760 @default.
• W2955950503 cites W2793905733 @default.
• W2955950503 cites W2887420845 @default.
• W2955950503 cites W2895319378 @default.
• W2955950503 cites W2912782389 @default.
• W2955950503 cites W2921207256 @default.
• W2955950503 cites W40325719 @default.
• W2955950503 doi "https://doi.org/10.1074/jbc.ra119.008875" @default.
• W2955950503 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6690684" @default.
• W2955950503 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31239352" @default.
• W2955950503 hasPublicationYear "2019" @default.
• W2955950503 type Work @default.
• W2955950503 sameAs 2955950503 @default.
• W2955950503 citedByCount "32" @default.
• W2955950503 countsByYear W29559505032020 @default.
• W2955950503 countsByYear W29559505032021 @default.
• W2955950503 countsByYear W29559505032022 @default.
• W2955950503 countsByYear W29559505032023 @default.
• W2955950503 crossrefType "journal-article" @default.
• W2955950503 hasAuthorship W2955950503A5002857264 @default.
• W2955950503 hasAuthorship W2955950503A5011923747 @default.
• W2955950503 hasAuthorship W2955950503A5020338130 @default.
• W2955950503 hasAuthorship W2955950503A5034817273 @default.
• W2955950503 hasAuthorship W2955950503A5036745515 @default.
• W2955950503 hasAuthorship W2955950503A5040906898 @default.
• W2955950503 hasAuthorship W2955950503A5050110044 @default.
• W2955950503 hasAuthorship W2955950503A5054490724 @default.
• W2955950503 hasAuthorship W2955950503A5084231456 @default.
• W2955950503 hasBestOaLocation W29559505031 @default.
• W2955950503 hasConcept C11960822 @default.
• W2955950503 hasConcept C166342909 @default.
• W2955950503 hasConcept C168258287 @default.
• W2955950503 hasConcept C169760540 @default.
• W2955950503 hasConcept C170493617 @default.
• W2955950503 hasConcept C185592680 @default.
• W2955950503 hasConcept C195794163 @default.
• W2955950503 hasConcept C26702167 @default.
• W2955950503 hasConcept C2776038425 @default.
• W2955950503 hasConcept C2778338918 @default.
• W2955950503 hasConcept C2778938600 @default.
• W2955950503 hasConcept C2779177108 @default.
• W2955950503 hasConcept C44796713 @default.
• W2955950503 hasConcept C55493867 @default.
• W2955950503 hasConcept C86803240 @default.
• W2955950503 hasConcept C95444343 @default.
• W2955950503 hasConcept C97029542 @default.
• W2955950503 hasConcept C98274493 @default.
• W2955950503 hasConceptScore W2955950503C11960822 @default.
• W2955950503 hasConceptScore W2955950503C166342909 @default.
• W2955950503 hasConceptScore W2955950503C168258287 @default.
• W2955950503 hasConceptScore W2955950503C169760540 @default.
• W2955950503 hasConceptScore W2955950503C170493617 @default.

• next